Procaps Group SA Total Liabilities
Procaps Group SA total liabilities. Based on the latest financial reports, Procaps Group SA (PROC) has total liabilities worth $460.10 Million USD as of September 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Procaps Group SA (PROC) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Procaps Group SA (2019–2022)
Total liabilities of Procaps Group SA from 2019 to 2022. This chart illustrates how Procaps Group SA's total liabilities have evolved over time, based on quarterly financial data. Explore PROC long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Procaps Group SA Competitors by Total Liabilities
The table below lists competitors of Procaps Group SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oriental Precision & Engineering Co.Ltd
KQ:014940
|
Korea | ₩110.71 Billion |
|
SaraminHR Co.Ltd
KQ:143240
|
Korea | ₩41.24 Billion |
|
LB Semicon Inc
KQ:061970
|
Korea | ₩445.64 Billion |
|
Rafael Microelectronics
TWO:6568
|
Taiwan | NT$318.71 Million |
|
Lokum Deweloper SA
WAR:LKD
|
Poland | zł281.65 Million |
|
Corner Growth Acquisition Corp
NASDAQ:COOL
|
USA | $12.68 Million |
|
Aftermath Silver Ltd
V:AAG
|
Canada | CA$1.02 Million |
|
American Resources Corp Class A
NASDAQ:AREC
|
USA | $75.72 Million |
Liability Composition Analysis (2019–2022)
This chart breaks down Procaps Group SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Procaps Group SA total assets.
Liquidity & Leverage Metrics
Procaps Group SA Total Liabilities Ratios Explained
Procaps Group SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 11.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Procaps Group SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Procaps Group SA (2019–2022)
The table below shows the annual total liabilities of Procaps Group SA from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $462.06 Million | -7.67% |
| 2021-12-31 | $500.48 Million | -18.52% |
| 2020-12-31 | $614.22 Million | +5.59% |
| 2019-12-31 | $581.67 Million | -- |
About Procaps Group SA
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more